- Loss of Smell More Common in COVID-19 Than Thought
- Psoriasis Meds Don’t Raise Risk of Severe COVID-19: Study
- Diet Drinks Don’t Do Your Heart Any Favors
- Lockdowns Can Widen Kids’ Waistlines – Here’s How to Curb That
- Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectivenes
- Health Highlights: Oct. 27, 2020
- Kidney Trouble Greatly Raises Odds for Fatal COVID-19
- MRIs Might Be Safe for Patients With Implanted Heart Devices
- More Evidence Masks Slow COVID’s Spread
- Dangerous COVID-19 Syndrome First Seen in Kids Also Strikes Adults
Clinical Trials Update: June. 3, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Irritable Bowel Syndrome (IBS)
This study will evaluate the effectiveness, safety, and tolerability of an investigational drug to treat IBS with diarrhea.
The research site is in Boise, Idaho.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/ibs.aspx.
—–
Healthy Volunteers
This study of an investigational medication is enrolling healthy men and women aged 18 to 65.
The research site is in Baltimore, Md.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/healthy_volunteers.aspx.
—–
HIV-Associated Diarrhea
This study is evaluating an investigational drug that may help control HIV-associated diarrhea. Candidates must be 18 or older.
The research site is in Chicago, Ill.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/HIV.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
